Oscar Health

Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Oscar Health reports robust growth and profitability outlook for 2023

Oscar Health's 2022 performance showcased strong growth in membership, improved financial ratios, and a focus on efficiency and profitability in the insurance business.
The company's strengths lie in exceeding targets for capital, stable premiums, and leveraging investment income for competitive advantage.
Challenges include financial transparency and managing risk pool dynamics, while opportunities exist in market expansion, PBM contract benefits, and margin expansion strategies.
Overall, Oscar Health's strategic focus on growth, efficiency, and profitability positions it well for future success in the insurance market.

Oscar Health achieves Q1 profitability, focuses on tech innovation

Oscar Health's Q1 2023 earnings call highlighted strong financial performance, operational efficiency, and a strategic focus on profitability priorities.
While facing challenges such as reshaping strategies and market-specific dynamics, the company is well-positioned to leverage opportunities for growth and innovation.
With a mission-driven approach, a growing member base, and a commitment to enhancing technology, Oscar Health aims to sustain profitability and market competitiveness.

Oscar Health reports strong Q2 earnings, eyes growth opportunities

Oscar Health's Q2 performance reflects positive trends in profitability, membership growth, and strategic planning for future expansion.
While facing challenges in pricing strategies and achieving profitability targets, the company is well-positioned to capitalize on growth opportunities.
With a focus on innovation, customer satisfaction, and market expansion, Oscar Health aims to strengthen its competitive position in the healthcare industry.

Oscar Health excels in Q3, eyes profitability in 2024

Oscar Health's Q3 2023 earnings call highlighted strong performance metrics, a focus on profitability in 2024, and strategic initiatives to drive growth and enhance member satisfaction. While facing challenges in narrowing EBITDA losses, the company remains optimistic about its trajectory and expressed confidence in its strategic direction and employee dedication.

Oscar Health achieves insurance profitability, eyes growth amid market changes

Oscar Health's Q4 2023 Earnings Call highlighted achievements in insurance company profitability and significant improvements in total company adjusted EBITDA.
The company is well-positioned for profitability in 2024, focusing on serving over 1.3 million members with new products and technology enhancements.
Challenges include navigating potential market dynamics changes due to ACA subsidy adjustments, but Oscar Health is proactively addressing these concerns.

Oscar Health posts record revenue and profitability, eyes market expansion

Oscar Health delivered robust Q1 results, showcasing strong revenue growth, improved profitability, and strategic market expansion initiatives.
Despite facing challenges in achieving total company adjusted EBITDA profitability, the company's financial stability and growth prospects remain promising.
With a focus on operational efficiency and long-term strategic vision, Oscar Health is well-positioned to capitalize on market opportunities and drive sustained growth.

Oscar Health reports strong Q2 results, eyes growth through technology

Oscar Health's Q2 2024 earnings call showcased robust financial performance, driven by revenue growth and improved EBITDA. The company's membership expansion and strategic focus on technology-driven engagement are key strengths. Challenges include policy uncertainties and meeting raised guidance, while opportunities exist in market resonance and technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Harvard Business School classmates Josh Kushner, Mario Schlosser, and Kevin Nazemi decide to start a company to demystify health insurance.

Oscar, named after Kushner's great grandfather, raises $51.5 million through Series A, AA, and AAA funding from Gary Vaynerchuk, Dave Gilboa, Khosla Ventures, Lerer Ventures, General Catalyst Thrive Capital, Founders Fund, Kal Vepuri, BoxGroup and more, with a pre-money valuation of $70 million.

Series A4 funding drops a nice $30 million from investors into Oscar's wallet, bumping its valuation to $310 million.

Oscar secures $80 million in Series A5 funding, mostly from Formation 8. Pre-money valuation reaches $500 million.

Nearly 150,000 members call themselves Oscar-insured across four states alone (NY, NJ, CA, & TX).

Oscar's member services team sets up camp in Tempe, Ariz.

Mount Sinai Health System partners to open the Oscar Center, offering primary care, mental health, and wellness services to members—sort of like a fancy urgent care. 😎

Oscar offers coverage to New York small businesses for their employees. 

The Cleveland Clinic collab drops in the Midwest market to cover individuals across northeastern Ohio. 

Oscar expands to new regions, including Tennessee, Ohio, Texas, New Jersey, and California.

Hey, y’all: A partnership with Humana helps Oscar cover small businesses up to 50 employees in Nashville, Tenn.

Series G round nets Oscar $165 million in funding, zooming the estimated value to a whopping $3.2 billion.

Alphabet (parent company to Google) decides to invest, cutting Oscar a check for $375 million.

The "Cigna + Oscar" collab brings together Cigna's vast network to Oscar's member-focused experience for small businesses. 

Gary Vaynerchuk and Khosla Ventures go for round 2, but this time, a sweet $225 million with the help of Builders VC.

Tiger Global Management invests $140 million in Oscar, as the company's member count exceeds 400,000.

Oscar begins trading on the New York Stock Exchange under the ticker $OSCR.

Shares of Oscar Health Inc. didn't pick a great day to go public, as the stock opened 7.7% above the initial public offering price despite better-than-expected pre-open investor demand. The digital health-insurance company offered 37 million shares in the upsized IPO, which priced at $39 each, above the recently raised expected range of between $36 and $38 a share.

Oscar Health stock stumbles out of the gate

Oscar had priced its shares at $39 apiece, above its target range of $36 to $38.

Shares of Oscar Health dip in NYSE market debut, begins trading at $36 per share

The next-generation health insurer will reap gross proceeds upward of $1.11 billion if buyers think the new price is right.

Oscar Health Raises IPO Price; Shares to Start Trading Today

Late last night Oscar Health, a tech-enabled medical insurance provider, priced its IPO at $39 per share. The final price came in $1 per share above its raised IPO guidance; Oscar Health had originally targeted a $32-$34 per-share IPO price.

Oscar Health prices IPO at $39 and secures a $9.5B valuation

The healthcare company will make its public equities market debut later on Wednesday.

Oscar Health Boosts Size of Its IPO to $1.4 Billion

Insurtech Oscar Health, co-founded by Joshua Kushner, raised $1.4 billion in an initial public offering (IPO) on a $7.9 billion valuation, The Financial Times reported on Wednesday (March 3).   Kushner, brother to Jared Kushner, former President Donald Trump's son-in-law, co-founded Oscar Health in 2012 with CEO Mario Schlosser and Kevin Nazemi, a former Microsoft executive.

Oscar Health IPO Raises $1.4 Billion On $7.9 Billion Valuation

Oscar Health said that it's priced its initial public offering at $39, raising $1.4 billion. The company twice raised the range of its pricing.

Oscar Health IPO prices above range to raise $1.4 billion

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) today announced the pricing of its initial public offering of 37,041,026 shares of its Class A common stock at a price to the public of $39.00 per share. Of the offered shares, 36,391,946 shares are being offered by Oscar and 649,080 shares are being offered by certain of Oscar's existing selling stockholders. The underwriters have a 30-day option to purchase up to an additional 5,556,153 shares of Class A common stock from Oscar at the in

Oscar Health, Inc. Announces Pricing of Initial Public Offering

Oscar Health Inc. disclosed Tuesday that the expected pricing of its initial public offering has increased, to boost what the digital health-insurance company was expected to raise by up to $124 million. The company is still offering 31.0 million shares in the IPO, but the IPO is now expected to price between $36 and $38 a share to raise $1.18 billion, up from previous expectations of between $32 and $34 a share to raise $1.05 billion.

Oscar Health IPO's expected pricing increased, lifting what company is raising to up to $1.2 billion

Venture-backed Oscar Health is almost as good at losing money as it is at raising it. Since it was founded in 2012, the health insurance startup, which is going public at a valuation of $8 billion, has captivated investors with the promise of upending health insurance with sleek technology.

One giant question is swirling around the IPO of hot health insurer Oscar: Can the startup ever make money?

Roblox

When private corporations offer shares of their company to the general public in order to obtain capital on the primary market, this process is known as an Initial Public Offering (IPO). There are a number of major upcoming IPOs that you need to watch out for this week.

Let's Take a Look At Some Upcoming IPOs This Week: Investors Should Track These Public Offerings

Only two traditional IPO listings are expected to price during the week of March 1. Here is a look at what investors should expect from the IPO offerings.

News for Oscar Health Stock (OSCR)